Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kouji Kunieda is active.

Publication


Featured researches published by Kouji Kunieda.


Digestive Diseases and Sciences | 1994

Percutaneous transhepatic microwave coagulation therapy for hepatocellular carcinoma proliferating in the bile duct.

Toshihito Seki; Yoshitugu Kubota; Masayuki Wakabayashi; Kouji Kunieda; Sei Nakatani; Tomohiro Shiro; Kyoichi Inoue

Hepatocellular carcinoma (HCC) often invades the portal system or hepatic veins. Along with recent increases in the incidence of HCC, there have been several reports of HCC proliferating in the bile duct and causing obstructive jaundice (1-4). Since radical hepatectomy is rarely possible in these cases, conservative therapy is the sole therapeutic modality. Transcatheter arterial embolization (TAE) is reported to be effective in some cases, but the number of studies is limited and the efficacy of the procedure has not been established (5-7). Surgical treatment was not possible and TAE we found to be ineffective in the present case of HCC proliferating in the bile duct. We applied percutaneous ethanol injection therapy (PEIT) (8, 9), percu taneous t ranshepat ic microwave coagulat ion therapy (PTMCT), and radiotherapy, and the combination produced satisfactory clinical results. To our knowledge, this is the first reported case in which local treatment was successfully applied to HCC that had infiltrated the bile duct.


Journal of International Medical Research | 1990

DIFFUSE CALCIFICATION IN GASTRIC CANCER

Kouji Kunieda; Masaru Okuhira; Toshiaki Nakano; Sei Nakatani; Jiro Tateiwa; Arata Hiramatsu; Takako Mizuno; Yasuko Shiozaki; Yoshiko Sameshima

The progressive expansion of calcification into the wall of the stomach and peritoneal metastatic foci was observed in a 31-year-old female with Borrmann type 4 calcified advanced gastric cancer. Despite treatment with systemic lentinan, uracil tegaful and mitomycin C, together with intraperitoneal injections of mitomycin C, OK-432 and prednisolone, the patient died 27 months after first presentation. The case provided a useful means of studying the mechanism of calcification.


International Hepatology Communications | 1995

Development of local necrosis and side-effects after hepatic injections of acetic acid solutions

M Imamura; Toshihito Seki; Kouji Kunieda; Masayuki Wakabayashi; Sei Nakatani; Tomohiro Shiro; Kyoichi Inoue

Abstract Acetic acid injection therapy has recently been studied as a treatment for hepatocellular carcinoma. Since trials of this therapy have just begun, both basic and clinical studies of it are presently required. Therefore, the efficacy and safety of this therapy as a treatment for hepatocellular carcinoma were examined in rats. When acetic acid was injected into normal rat liver, the extent of necrosis at the site of injection expanded in a dose-dependent manner. At concentrations of 30% and above, acetic acid began to prove fatal, and mortality increased in a dose-dependent fashion. At a concentration of 45% and above, all rats died within 2 days after injection due to acute multi-organic circulatory failure. On histological examination, distinct thorombus formation was observed in the liver. We conclude that additional detailed examination of the effects of various amounts and concentrations of acetic acid and of the effects of acetic acid injection on other organs should be performed prior to clinical application of this therapy.


Digestive Endoscopy | 1990

Acute Gastric Lesions Induced by Transcatheter Arterial Embolization and Intra-arterial Infusion Chemotherapy for Hepatocellular Carcinoma

Masaru Okuhira; Toshiaki Nakano; Kouji Kunieda; Tomoko Kitajima; Yasuo Amou; Tsuneyuki Nonaka; Arata Hiramatsu; Takako Mizuno; Yoshiko Sameshima

We performed an endoscopic study of the acute gastric lesions induced by transcatheter arterial embolization (TAE) and infusion chemotherapy (one shot infusion: OSI). Forty‐eight patients with primary hepatocellular carcinoma were investigated, and of them, 25 received TAE and 23 were treated with OSI. Endoscopy was performed within 1 week both before and after therapy and any gastric mucosal changes were noted. Before treatment, all patients had gastric lesions such as redness, erosion, hemorrhage and ulcer. These lesions were exacerbated or new lesions appeared after both TAE and OSI in about 50% of the subjects, and no significant difference in the incidence of lesions was observed between these two treatments. Moreover, there was no significant correlation between the exacerbation or new appearance of gastric lesions and the Childs classification, the catheter position, or the presence or absence of A‐P shunt or portal thrombus.


Digestive Endoscopy | 1990

Benign Strictures of the Intrahepatic Bile Ducts Managed with Percutaneous Transhepatic Cholangioscopy: A Case Report

Yoshitsugu Kubota; Toshihito Seki; Takashi Yamaguchi; Kouji Kunieda; Kazuhiro Tani; Hideyuki Kin; Takako Mizuno; Yoshiko Sameshima

Benign strictures of the intrahepatic bile ducts were detected, by percutaneous transhepatic cholangioscopy combined with forceps biopsies, in a patient who presented symptoms suggesting cholangitis. The patient was successfully treated by non‐operative stricture dilation techniques, with the aid of cholangioscopy. In this paper, the usefulness of percutaneous transhepatic cholangioscopy for the management of benign biliary strictures is discussed.


British Journal of Cancer | 1993

Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer.

Kouji Kunieda; Toshihito Seki; S. Nakatani; M. Wakabayashi; T. Shiro; Kyoichi Inoue; M. Sougawa; R. Kimura; K. Harada


Digestive Endoscopy | 1990

Long‐term Efficacy of Percutaneous Transhepatic Choledochoscopic Y AG Laser Therapy for Malignant Biliary Obstruction

Yoshitsugu Kubota; Toshihito Seki; Kouji Kunieda; Yoshitsugu Nakahashi; Takashi Yamaguchi; Jiro Tateiwa; Takako Mizuno; Yasuko Shiozaki; Yoshiko Sameshima


Kanzo | 1991

Ultrasonically guided percutaneous ethanol injection therapy for large sized hepatocellular carcinoma.

Toshihito Seki; Yoshitsugu Kubota; Kouji Kunieda; Yoshihiko Kanou; Masahiro Sato; Tomohiro Shiro; Takako Mizuno; Yasuko Shiozaki; Kyouichi Inoue


Oncology Reports | 1998

Change of temperature in mouse tumour tissue immersed in a water bath at 44 degrees C.

M Imamura; Toshihito Seki; Toru Tamai; Kouji Kunieda; S Nakatani; Noriyo Yamashiki; Akira Nishimura; Taiichi Nakagawa; Kyoichi Inoue; Kenji Nagata; M Kasahara; Akiharu Okamura; K Harada


Oncology Reports | 1996

Potential applicability of clinical hyperthermia using a Thermotron-RF8 as assessed from thermal distribution in an agar phantom containing hydroxyapatite

M Imamura; Toshihito Seki; Kouji Kunieda; S Nakatani; Toru Tamai; Kyoichi Inoue; Kenji Nagata; Yoshimasa Tanaka; Y Obiya; K Harada

Collaboration


Dive into the Kouji Kunieda's collaboration.

Top Co-Authors

Avatar

Toshihito Seki

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Kyoichi Inoue

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

M Imamura

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Takako Mizuno

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

K Harada

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Sei Nakatani

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Tomohiro Shiro

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masaru Okuhira

Kansai Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge